Affiliations 

  • 1 Department of Biology, Kharazmi University, Tehran, Iran; Department of Medical Genetics, Special Medical Center, Tehran, Iran
  • 2 Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 3 Department of Medical Genetics, Special Medical Center, Tehran, Iran
  • 4 Department of Medical Genetics, Special Medical Center, Tehran, Iran; Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, D.C., United States of America
  • 5 Department of Medical Genetics, Special Medical Center, Tehran, Iran; Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
PLoS One, 2014;9(9):e106656.
PMID: 25216246 DOI: 10.1371/journal.pone.0106656

Abstract

Oculocutaneous albinism (OCA) is a heterogeneous group of autosomal recessive disorders resulting from mutations of the tyrosinase (TYR) gene and presents with either complete or partial absence of pigment in the skin, hair and eyes due to a defect in an enzyme involved in the production of melanin. In this study, mutations in the TYR gene of 30 unrelated Iranian OCA1 patients and 100 healthy individuals were examined using PCR-sequencing. Additionally, in order to predict the possible effects of new mutations on the structure and function of tyrosinase, these mutations were analyzed by SIFT, PolyPhen and I-Mutant 2 software. Here, two new pathogenic p.C89S and p.H180R mutations were detected in two OCA1 patients. Moreover, the R402Q and S192Y variants, which are common non-pathogenic polymorphisms, were detected in 17.5% and 35% of the patients, respectively. The outcome of this study has extended the genotypic spectrum of OCA1 patients, which paves the way for more efficient carrier detection and genetic counseling.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.